INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 427m ago
HOUSE PTR26m ago
SEC 13F26m ago
ROBINHOOD CHAIN26m ago
Corporate insider
GS

Gheuens Sarah

Chief Medical OfficerCIK 0001881190

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 3
Max Insider Score11
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
2
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$197K
7,866 sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    AGIOS PHARMACEUTICALS, INC.Chief Medical Officer · Oct 23, 2026
11
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL
$296K
7,866 sh
Oct 26, 2026
Oct 28, 2026
traded Oct 26, 2026
+2d
SEC FORM 4

Evidence

7
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
7,866 sh
Oct 26, 2026Oct 28, 2026
traded Oct 26, 2026
+2dSEC FORM 4

Evidence

3
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$37K
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

8
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$56K
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC FORM 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$13K
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

1
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$19K
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

0
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
500 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence